OnCo
institutionsInstitution

IRCCS Ospedale San Raffaele

aka San Raffaele Hospital, OSR, Università Vita-Salute San Raffaele

Milan's research hospital known for engineered T-cell therapies, gene therapy, high-volume pancreatic surgery and HER2 breast cancer trials.

Ospedale San Raffaele is a private IRCCS research hospital with its own university and a strong gene and cell therapy tradition through the San Raffaele Telethon Institute for Gene Therapy. Fabio Ciceri's haematology and transplant unit and Chiara Bonini's experimental haematology laboratory developed suicide-gene-modified donor lymphocytes and TCR-edited T cells, Luca Gianni's breast oncology programme led the NeoSphere trial of dual HER2 blockade with pertuzumab and trastuzumab, and Massimo Falconi's pancreatic surgery unit is among Europe's highest-volume centres. The hospital runs neuro-oncology, urology, radiotherapy and a phase 1 unit, and pathology under Claudio Doglioni supports genomics-driven trials.

Location
Milan, IT
Type
hospital · Università Vita-Salute San Raffaele
Website
Newsweek 2026 oncology rank
Not in top 300 listing used
OnCo score
#154 · 30 points (0 Newsweek + 0 NCI + 30 from 15 linked objects) · ranking

Programmes

5top
  • Engineered T-cell and gene therapy
  • Haematology and transplantation
  • Pancreatic surgery
  • HER2-positive breast cancer trials
  • Neuro-oncology

Connected

15top

Pages like this

not linked directly; found by shared links